Why the Wegovy Pill Matters for Patients For years, many patients delayed treatment because they didnt want injections or struggled with access and cost
Im looking forward to seeing and feeling some results
For pediatric patients ages 12 and over, the maintenance dose is 2.4 mg once weekly
Sublingual tirzepatide bioavailability: approximately 25 to 35% (varies by formulation and technique)
Record dose amount, date, time, and injection site Review your last dose and see what is coming next Use reminders and a Shot Day checklist to stay consistent Rotate injection sites with a clear record View medication-level trends across 3 days, 30 days, 90 days, or 1 year Medication-level visuals are informational estimates based on your logs and are not dosing guidance
Months six through nine: peak shedding and early recovery For most patients, shedding peaks around months four through seven and then gradually diminishes